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Metallosomes for biomedical applications by
mixing molybdenum carbonyl metallosurfactants
and phospholipids†
M. Marín-García, a N. Benseny-Cases, b M. Camacho, c Y. Perrie,d
J. Suades *e and R. Barnadas-Rodríguez *a
New supramolecular systems have been prepared by mixing molybdenum organometallic metallosurfac-
tants M(CO)5L and M(CO)4L2 {L = Ph2P(CH2)6SO3Na} with the phospholipid phosphatidylcholine. The ana-
lysis of the resulting supramolecular structures using dynamic light scattering and cryo-transmission elec-
tron microscopy has shown the formation of diﬀerent aggregates depending on the metallosurfactant/
phospholipid ratio, as well as a signiﬁcantly diﬀerent behaviour between the two studied metallosurfac-
tants. Mixed vesicles, with properties very similar to liposomes, can be obtained with both compounds,
and are called metallosomes. The formation of the mixed aggregates has also been studied by micro-
ﬂuidics using MeOH and EtOH as organic solvents, and it has been observed that the size of the aggre-
gates is strongly dependent on the organic solvent used. In order to analyse the viability of these mixed
systems as CO Releasing Molecules (CORMs) for biomedical applications, the CO release was studied by
FT-IR spectroscopy, showing that they behave as photo-CORMs with visible and ultraviolet light. Toxicity
studies of the diﬀerent mixed aggregate systems have shown that metallosomes exhibit a very low toxicity,
similar to liposomes that do not contain metallosurfactants, which is well below the results observed for
pure metallosurfactants. Micro-FTIR microscopy using synchrotron radiation has shown the presence of
metallosurfactants in cells. The results of this study show the inﬂuence of the length of the hydrocarbon
chain on the properties of these mixed systems, compared with previously reported data.
Introduction
The first references to the concept “metallosurfactant” (MTS)
were published in the 1990s and, in general, this term was
used to refer to molecules that behave as surfactants and
contain a metal atom in the molecular structure.1 Since
amphiphilic molecules with surfactant properties can help
obtain supramolecular structures by self-assembly in an
aqueous solution, this simple concept can also obtain supra-
molecular structures with metallic atoms. This is an attractive
idea that has been studied with a broad range of diﬀerent
aims (anticancer agents,2 antimicrobial compounds,2,3 cataly-
sis,4 corrosion mitigation,5 labelling phospholipid mem-
branes,6 light-driven hydrogen generation,7 magnetic reso-
nance imaging,8 metallomesogens,9 nanoparticles,10 opto-
electronic devices,11 and templates for mesoporous
materials12) as well as being reviewed from diﬀerent points of
view.13
Since surfactants are amphiphilic molecules that contain
hydrophobic groups and a polar group, and considering that
in a wide range of metal complexes the resulting coordinated
metal atom is located in a polar region of the molecule, in a
large number of the reported MTSs the metal atom is placed
in the polar head group of the surfactants. This is the case for
metallic complexes with alkyl amines or organic carboxylates
that contain a long hydrophobic chain (which can be seen
schematically in the drawing (a) of Scheme 1). Thus, a large
number of the reported MTSs fit this representation in which
the metal atom is located in the polar group of the amphi-
philic molecule. However, other designs are possible, and
exactly the opposite situation is shown in the drawing (b) of
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Scheme 1 (an MTS that contains the metal atom embedded in
the hydrophobic tail). These kinds of compounds can be pre-
pared by means of an organometallic approach, because it
makes it possible to locate a metallic atom in a hydrophobic
environment. Although these MTSs are much less common,
some examples have been reported, such as the ferrocenyl sur-
factants.14 Following this approach, we undertook the study of
MTSs with metal carbonyls,15,16 since their non-polar pro-
perties allow the metallic atom to be placed in the hydro-
phobic region of the MTSs. The self-assembly of these com-
pounds can lead to supramolecular systems with metal carbo-
nyls and, from their broad range of possible applications, we
chose to focus on the study of these supramolecular metal car-
bonyls as CO releasing molecules (CORMs) for biomedical
applications. Thus, we demonstrate that molybdenum carbo-
nyls with the phosphine ligands Ph2P(CH2)nSO3Na {n = 2 (L2),
6 (L6), 10 (L10)} form vesicular aggregates in aqueous media
and these supramolecular systems can act as CO releasing
molecules {Mo(CO)4L2 and Mo(CO)5L; L = L2, L6, L10}.
However, a problematic point for a possible application of
these compounds in medicine is that the supramolecular
arrangements formed by these MTSs are labile systems and
they lead to diﬀerent kinds of aggregates depending on the
concentration of MTSs, and dilution causes disaggregation of
vesicles. In order to improve the properties of these supramole-
cular systems for biomedical applications, we undertook the
study of mixed systems of MTSs and phospholipids. In a
recent communication17 we showed that, in contrast to the
aggregates formed by pure MTSs, mixed systems of MTSs and
phospholipids lead to vesicular aggregates, very similar to lipo-
somes, which are stable under dilution. These new systems
can be named metallosomes, because they are vesicles with
entrapped water, and their membrane is analogous to the clas-
sical lipid bilayer (Scheme 2). They exhibit properties very
similar to those of liposomes, as stability under dilution, and
size control using standard methods such as extrusion.
Furthermore, it should be highlighted that the most interest-
ing result of this study was to establish that the toxicity of
metallosomes is at least ten-fold lower than that of the MTS
aggregates without phospholipids. As far as we know, only a
very limited number of aggregates classified as metallosomes
have been reported,18 most of them aimed as possible bio-
medical applications.
In our previous communication were reported the prelimi-
nary results of our work with metallosomes, which was limited
to molybdenum complexes with the ligand with the
shortest hydrocarbon chain (L2), Mo(CO)4(L2)2 (TCOL2) and
Mo(CO)5(L2) (PCOL2). In the present paper, the study has been
extended to metal complexes with the ligand L6 {Mo(CO)4(L6)2
(TCOL6) and Mo(CO)5(L6) (PCOL6)} in order to analyse the
influence of the length of the hydrocarbon chain of the ligand
on the metallosome properties.
Results and discussion
Structures of the mixed aggregates obtained by the film
hydration method
The formation of binary mixed structures composed of an
MTS with 6 carbon atoms in the hydrocarbon chains (PCOL6
or TCOL6) and soy phosphatidylcholine (SPC) was studied by
hydrating and vortexing a homogeneous dry thin film of the
substances prepared by rotary evaporation of an organic solu-
tion. The SPC concentration of the suspensions was kept con-
stant at 3 mM while the MTS concentration ranged from 0 to
10 mM. Dynamic light scattering (DLS) analysis shows (Fig. 1)
a diﬀerent eﬀect of both MTSs on the type of aggregate
Scheme 1 Representation of metallosurfactants with the metal (M) in
the polar head group (a) or in the hydrophobic region (b). Scheme 2 Formation of liposomes with phospholipids or metallo-
somes by mixing metallosurfactants and phospholipids.
Fig. 1 DLS analysis of the size distribution of TCOL6/SPC aggregates
(blue) and PCOL6/SPC aggregates (orange) as a function of the concen-
tration of each MTS (mean ± std. dev.; n ≥ 3). White circles correspond
to aggregates obtained after addition of Triton X-100. The SPC concen-
tration was kept constant (3 mM). The area of the circles is proportional
to the percentage of aggregates of a given diameter.
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formed. For the case of the MTS bearing 2 hydrocarbon
chains, TCOL6, its progressive concentration increase from 0
to 4 mM produces a concomitant decrease in the size of the
structures formed. As can be observed, the size of the aggre-
gates changes more than 2 orders of magnitude: initial lipo-
somes obtained with no MTS are of about 1 μm in diameter;
TCOL6 incorporation between 0.5 and 2 mM still renders
structures located in the vesicle domain but with a smaller
size; and, finally, in the 3 to 4 mM nanometre range, structures
of approximately 8 nm are detected. If Triton X-100 is added to
the suspensions at a solubilising concentration (10 mM), vesi-
cles are totally disrupted and mixed micelles of about 8 nm
are obtained. However, when the surfactant is added to the
small aggregates no significant change of the size is observed.
Surprisingly, at a TCOL6 concentration higher than 4 mM
there is a sharp increase of the size and micrometre sized
aggregates, which sediment in a few minutes, are detected,
part of them having a size located at the higher limit of detec-
tion of the device (6.5 µm). The evolution of the system is
quite diﬀerent for the case of PCOL6/SPC mixtures: apparently
there are no remarkable changes in the vesicle size.
Incorporation of TCOL6 into the SPC phospholipid bilayers
only causes the formation of vesicles of about 90–100 nm, but
the main population is maintained close to the initial size of
the pure SPC liposomes, at approximately 1000 nm. As for the
case of TCOL6, addition of Triton X-100 also causes total
vesicle disruption.
The morphology of all the previously described systems was
studied by cryo-TEM and optical microscopy. As can be
observed (Fig. 2A and B), at a low concentration of TCOL6 the
mixed vesicles are mostly uni- and oligo-lamellar, and show a
smooth and regular membrane. Some of these vesicles exhibit
a central dark area, which is indicative of their protruding out
of the vitrified film (thickness about 10 to 500 nm).19 Between
3 and 4 mM of TCOL6 very small aggregates are observed, with
some of them having the shape of a disk or a bar (Fig. 2C).
The presence of both shapes can be explained by the for-
mation of bicelles, that is, small fragments of SPC bilayers
forming a circular disc surrounded by a rim of a short-chain
surfactant, in our case, TCOL6. Orientation of the former
aggregates in the vitrified samples allows the observation of
both thin bars and small disks when they lie perpendicular or
parallel to the grid, respectively.19 As regards the samples with
a TCOL6 concentration greater than 4 mM, no large aggregates
were visible by cryo-TEM, although very large rods were
observed by optical microscopy (Fig. 2D). This fact may be a
consequence of the sample treatment for cryo-TEM analysis:
very large structures are usually removed from the grid during
Fig. 2 Images of mixed systems of MTS and SPC. A and B: Cryo-TEM pictures of TCOL6/SPC 1 : 3 mM/mM vesicles. C: Cryo-TEM image of TCOL6/
SPC 3 : 3 mM/mM bicelles (arrows). D: Optical microscopy picture of TCOL6/SPC 10 : 3 mM/mM rods. E and F: Cryo-TEM images of PCOL6/SPC
vesicles at 6 : 3 and 10 : 3 mM/mM, respectively.
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the blotting process, since they protrude far too much due to
the thickness of the water film. The structure of PCOL6/SPC
aggregates was quite diﬀerent from that of the TCOL6/SPC
ones. On the one hand, when a PCOL6/SPC ratio of 3 : 6 mM/
mM was reached, small vesicles and also micrometric multive-
sicular (Fig. 2E) and multi-lamellar vesicles (MLVs) were
observed. In all cases, they exhibit the same smooth mem-
brane as TCOL6/SPC aggregates. On the other hand, when the
relative amount of MTS increases, vesicles are deformed, show
a rough membrane and furthermore, branched thread-like
micelles connected to the vesicles appear, as can be seen in
Fig. 2F for PCOL6/SPC 10 : 3 mM/mM.
Habitually, one required characteristic of aggregated
systems intended for biomedical applications is their stability
upon dilution. This is important, because their structure
should be preserved once they are in the fluid biological
media, otherwise their cargo would be disseminated in a non-
specific manner during their journey to their target. Knowing
that pure MTSs are not stable upon dilution, the stability of
mixed vesicles and bicelles was monitored by DLS, by perform-
ing progressive dilutions of initial concentrated samples. The
results show that both vesicles and bicelles of TCOL6/SPC were
stable upon dilution for at least two orders of magnitude,
since no significant change was observed in the mean dia-
meter (Fig. 3). Positive and negative controls were a bicellar
suspension of phospholipids and pure SPC liposomes, respect-
ively (Fig. S1, ESI†). In contrast, PCOL6/SPC systems showed a
diﬀerent behaviour compared to TCOL6/SPC ones. While vesi-
cles with a high content of SPC showed no change of the
vesicle size upon dilution (Fig. 3), those with a low SPC
content were non-stable (NS) and showed a decrease in the dia-
meter (from about 700 nm to 250 nm) when progressively
diluted 100 times. Since it is known that SPC membranes are
not altered by dilution, this phenomenon has to be a conse-
quence of the release of PCOL6 from the mixed aggregates
when the equilibrium between the free and the vesicular MTS
is modified. Note that the diameter change is more intense at
a PCOL6 concentration of about 1.2 mM (normalised concen-
tration 0.1; initial concentration of the system 12 : 3.6 mM/mM
PCOL6/SPC), that is, the critical micellar concentration of
PCOL6.15,16
It can be observed that sizes measured by DLS match with
those observed by cryo-TEM, especially for submicron vesicles
which are well within the detection range of both techniques.
It is apparent that despite the diﬀerence in the length and
shape between both MTS and SPC, hydration of binary films
allows the spontaneous formation of mixed aggregates. This
fact parallels the behaviour of the mixtures of PCOL2 and
TCOL2 with SPC, which also form aggregates,17 even though
the length of their hydrocarbon chains (2 methylene groups) is
one-third those of PCOL6 and TCOL6. Thus, the known
capacity of phospholipid fatty acid chains for filling (by
rotation) the gaps generated inside the bilayers caused by the
inclusion of short and bulky molecules should explain the for-
mation of mixed vesicles.
However, it should be highlighted that some significant
diﬀerences were found between the aggregates formed by the
molybdenum complexes of the L2 and L6 families. For the
case of TCOL6/SPC mixtures, when the relative amount of MTS
is too high, membranes destabilise and other structures are
formed (first bicelles and, finally, very large rods). Both aggre-
gates were not observed with TCOL2, since only micelles were
obtained at high MTS/SPC ratios. The evolution of the PCOL6/
SPC systems is also quite diﬀerent from that of the PCOL2/SPC
systems, where a progressive decrease of the aggregate size is
observed upon the increase of the MTS/SPC ratio and micelles
are obtained. This is not the case for PCOL6, and a progressive
overloading of the membranes takes place at high PCOL6 to
SPC ratios. The presence of very dark vesicles indicates the
extreme protrusion of these aggregates out of the film, consist-
ent with a very big size, which is not detected by DLS since it
is far away from its upper limit of detection. Moreover, the
vesicle deformation and the roughness of the membrane
(Fig. 2F) are indicative of the diﬃcult packing of the vesicular
membranes, which tend to form thread-like structures and
showed instability upon dilution. Vesicle deformation have
been observed in other binary systems as, for example distear-
oylphosphatidylcholine/cholesterol liposomes at a 60/40 molar
ratio.20 This cholesterol content is close to that which causes
formation of tubular liposomes, possibly caused by the for-
mation of phase domains into the bilayer.
Structure of the mixed aggregates obtained by microfluidics
During their preparation, the characteristics of surfactant
aggregates can be controlled by several factors, such as the
concentration of organic solvents, ionic strength, temperature,
Fig. 3 Stability of MTS/SPC aggregates upon dilution: TCOL6/SPC
12 : 36 mM/mM (blue circles); TCOL6/SPC 12 : 12 mM/mM bicelles (blue
squares); PCOL6/SPC 12 : 36 mM/mM vesicles (orange circles); and
PCOL6/SPC 12 : 3.6 m/mM non-sable vesicles (orange triangles).
Previous concentrations correspond to the initial concentrations (nor-
malised concentration = 1). Mean ± std. dev.; n ≥ 2.
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or shear stress.21 Some of the former factors are involved in
the microfluidic process, technology used to obtain diﬀerent
types of drug delivery systems,22 a reason why their eﬀect on
the formation of mixed MTS vesicles was studied. Tables
included in Fig. 4 show the experimental results for the level
combinations of the Total Flow Rate (TFR) and the water to
solvent (methanol or ethanol) Flow Rate Ratio (FRR) for the
PCOL6/SPC 1 : 3 mM/mM system. The corresponding fitted
surfaces of response are shown (other results are shown in
Fig. S2, ESI†). As can be observed, the size of the aggregates
clearly depends on the type of organic solvent used: at any
given combination of TFR and FRR, the size of the aggregates
when using methanol is always smaller than that obtained
when the solvent used is ethanol. Regarding the eﬀect of the
total and relative flows, TFR and FRR have a big influence on
the size when methanol is used, while only FRR is the main
factor when the solvent used is ethanol. The study of the influ-
ence of ionic strength (between 0 and 155 mM of NaCl) was
carried out at several TFR values (2, 10 and 18 mL min−1) and
by fixing the solvent (methanol) and the FRR (at 3). Results for
the PCOL6/SPC 1 : 3 mM/mM system are shown in Fig. 5 (see
results for the TCOL6/SPC 1 : 3 mM/mM system in Fig. S3,
ESI†) and as can be observed there is a concomitant increase
of the ionic strength and the size of the vesicles at any of the
TFRs assayed. Finally, the morphology of big PCOL6/SPC vesi-
cles corresponds to multi-lamellar structures (Fig. 6), which is
highly diﬀerent from that obtained by the film method (Fig. 2).
The previously expressed results can be compared with
those obtained by other authors when phospholipid liposomes
are prepared using isopropanol or ethanol as the solvent. In
these cases, the general finding is that the FRR is a major
factor in regulating liposome size, with both variables being
Fig. 4 Mean diameter of PCOL6/SPC 1 : 3 mM/mM vesicles obtained by microﬂuidics using methanol (A) or ethanol (B) as the solvent as a function
of the Flow Rate Ratio (FRR) and the Total Flow Rate (TFR). Fitted surface responses obtained from the experimental points are given (mean ± std. dev.;
n ≥ 2).
Fig. 5 Mean diameter of PCOL6/SPC 1 : 3 mM/mM vesicles obtained by
microﬂuidics as a function of the ionic strength of the aqueous medium,
using methanol as the solvent, FRR = 3, and TFR = 2 (circles), 10
(squares) and 18 mL min−1 (triangles). Mean ± std. dev.; n ≥ 2.
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inversely related.23 This eﬀect is a consequence of the drop in
the final solvent concentration due to the FRR increase, which
reduces liposome fusion.24 Vesicle fusion, like many other
alterations of membrane properties (such as permeability,
surface tension, and area per molecule),25 is driven by alcohol
insertion into phospholipid bilayers. In this sense, MTS/SPC
vesicular systems exhibit a behaviour analogous to that of lipo-
somes, since any FFR increase, using either methanol or
ethanol as solvent, causes a decrease in the vesicle size. On the
other hand, there is a big diﬀerence in the vesicle size range
depending on the solvent used. Observe that while vesicles
obtained in the presence of the shortest chain alcohol (metha-
nol) are always located at the domain of the small unilamellar
vesicles (SUVs) with, for example, a maximum diameter of
about 50 nm at TFR = 2 and FRR = 1, those obtained in the
presence of ethanol range from SUVs to MLVs, and achieve
micrometre size under the former stated conditions. This
noticeable diﬀerence can be a consequence of the diﬀerence
in the fusogenic activity exhibited by alcohols depending on
their chain length. Paxman et al.26 found that those alcohols
with 2 to 4 carbon atoms increase vesicle fusion to planar
bilayers, and that methanol inhibits it. This could explain why
vesicles obtained by microfluidics in the presence of methanol
should preserve their small size and those, contrarily, with a
high content of ethanol (low FRR) in the bulk should fuse and
yield large multi-layered vesicles, as observed by cryo-TEM
(Fig. 6).
CO release from mixed aggregated systems upon irradiation
TCOL6 and PCOL6 (and their derived mixed aggregates),
which contain an Mo atom linked to several CO groups, not
only have a very particular structure because of their hydro-
phobic domain, but also encompass the possibility to become
CO releasing molecules (CORMs). Previous studies carried out
with MTSs with shorter chains (2 carbon atoms, i.e., TCOL2
and PCOL2) demonstrated that they are stable in the dark, and
that UVA and visible irradiations trigger CO release as gas.17
This capability shows that, in fact, these molecules are photo-
CORMs, and that their diﬀerent mixed aggregated structures
can be used as drug (CO) delivery systems with potential bio-
medical applications.27
With these precedents, the CO releasing properties of
TCOL6 and PCOL6 mixed systems were studied and the results
are shown in Fig. 7A and B. The FTIR spectra monitors the
decrease of the infrared CO absorption bands of both mole-
cules under UVA light (λmax = 365 nm). The insets of Fig. 7
Fig. 6 Cryo-TEM picture of PCOL6/SPC 1 : 3 mM/mM vesicles obtained
by microﬂuidics using ethanol as the solvent at TFR = 10 mL min−1 and
FRR = 1.
Fig. 7 Infrared spectra of (A) TCOL6/SPC 10 : 10 mM/mM and (B) PCOL6/SPC 10 : 30 mM/mM under irradiation with UVA (365 nm) at diﬀerent
times. Inset A: Changes in the relative area of the peak at 2017 cm−1 of TCOL6/SPC aggregates upon illumination with UVA (black) or visible light
(blue). Inset B: Changes in the relative area of the peak at 2070 cm−1 of PCOL6/SPC aggregates upon illumination with UVA (black circles), visible
light (white circles) or kept in the dark (grey squares). Mean ± std. dev.; n = 2.
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show the relative changes of the 2017 cm−1 and 2070 cm−1
bands for TCOL6 and PCOL6, respectively, with UVA or visible
irradiation. For a given MTS and type of light, there were no
significant diﬀerences between the diverse aggregated systems,
a reason why their results are shown in a single plot. As can be
observed, TCOL6 and PCOL6 are photo-CORMs, with UVA
being the most eﬀective light to deliver CO. However, note that
visible light is also active, as it was for TCOL2 and PCOL2. The
parallel behaviour of both families of MTS indicates that the
length of the hydrocarbon chain has no eﬀect on their CO
releasing capability.
Toxicity of MTS aggregates on human fibroblast cell cultures
Toxicity assays were carried out for the diﬀerent mixed aggre-
gated systems, and also for pure MTS (with no phospholipid)
and SPC liposomes. The results show (Fig. 8) that, from a
general point of view, the pentacarbonyl complex is more toxic
than the tetracarbonyl complex, as was in the case of the com-
plexes of the L2 family.17 When cell cultures were incubated
with pure MTSs, the LC50 values were 148 ± 44 μM and 53 ±
0.03 μM for TCOL6 and PCOL6, respectively (calculated using
the sigmoidal Hill equation). As regards the mixed TCOL6
systems, the most toxic aggregates were the TCOL6/SPC rods,
with an LC50 value of 234 ± 14 μM. The TCOL6/SPC bicelles
were less toxic, with an LC50 value of 421 ± 47 μM. In contrast,
the vesicular PCOL6/SPC vesicles showed no toxicity, and the
same cell viability as that of pure liposomes was obtained. The
two types of vesicles obtained with PCOL6 exhibited a very
diﬀerent behaviour. While the stable to dilution aggregates
were non-toxic in the studied range of concentrations, the
unstable ones were highly toxic, with an LC50 value of 53 ±
0.1 μM, equivalent to that of the pure PCOL6 sample.
These results are consistent with toxicity being dependent
on the type of the MTS aggregate. The critical micellar concen-
tration of TCOL6 and PCOL6 is about 1 mM.15,16 Thus, at all
the concentrations of the viability study, the pure MTSs only
exist as a monomer in the bulk, since the vesicles that they
form in the stock solutions disaggregate once they are added
to the cell incubation medium. The same is true for the NS-
vesicles of PCOL6/SPC, which also partially disaggregate upon
dilution and, thus, release free PCOL6 (Fig. 3). The three pre-
vious formulations exhibit the highest toxicity. In contrast,
bicellar TCOL6/SPC aggregates are stable upon dilution, are
about 8 nm in diameter, and exhibit an LC50 value higher than
that of any one of the previously mentioned systems. Finally,
the large and stable vesicles of TCOL6/SPC and PCOL6/SPC
exhibited no toxicity in the studied range. This relationship
between size/stability of the MTS aggregates and their toxicity
is apparently broken by the toxicity of the TCOL6/SPC rods,
which is higher than that of the bicelles, but it has to be taken
into account that, as was previously stated, these very large
structures rapidly sediment. Thus, rods are in close contact
with the cells during the 24 h incubation and this should
increase their toxicity.
Micro-FTIR spectroscopy of cells incubated with MTS
aggregates
The main objective of the acquisition of micro-infrared spectra
of cell cultures treated with mixed MTS/SPC systems was to
determine to what extent the complexes could penetrate into
the cells. This objective had the advantage of the strong IR
absorption of the CO groups of the MTSs which, on the other
hand, are not overlapped with any other absorption bands of
the cell components. Principal Component Analysis (PCA) in
the MTS CO region allowed the spectra to be classified accord-
ing to the presence of MTS. The PCA results for the MTS CO
region show a diﬀerent distribution between the analysed
systems (Fig. S4 and S5, ESI†). No outliers to the control (non-
treated cells) were found for pure SPC liposomes, due to the
absence of MTS CO bands. In the case of mixed TCOL6/SPC
Fig. 8 Viability of human dermal ﬁbroblasts after exposure for 12 h (mean ± std. dev.; n ≥ 4) to TCOL6 (blue) or PCOL6 (orange). They were adminis-
tered in free form (black dashed) or mixed with SPC as stable vesicles (blue or orange plain), bicelles (blue dotted), non-stable vesicles (orange
dotted) or rods (blue dashed). The MTS to SPC molar ratios were 1 : 3 for TCOL6 and PCOL6 stable vesicles; 3 : 3 for TCOL6/SPC bicelles; 10 : 3 for
PCOL6/SPC non-stable vesicles; and 10 : 3 for TCOL6/SPC rods. Pure SPC liposomes (white) were used as blanks and in these incubations SPC con-
centrations were the same as those of the respective treatments of mixtures of SPC and MTS.
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systems, a significant number of outliers were found for vesi-
cles only at 1000 μM (19%), bicelles (25%), and rods at 250
and 500 μM (94 and 99%, respectively), due to the absence of
MTS CO bands. In contrast, all the checked PCOL6/SPC aggre-
gates exhibited a large percentage of outliers. For the stable to
dilution vesicles at 250 and 500 μM, they were about 85 and
76%, respectively, with the NS-vesicles showing 100%.
A relative estimation of the MTS interaction with the cells
was obtained by the ratio between the area of one of the CO
bands of the MTS and the amide I band located at 1650 cm−1,
which is proportional to the amount of protein in the cells.
The results are shown in Fig. 9 and, as can be observed, the
significant diﬀerences as regards the control (median compari-
son by the Mann–Whitney U test) were obtained with the same
aggregated systems that provided significant outliers in the
PCA. The data also show that the MTS internalisation is depen-
dent on the type of aggregate, since bicelles, rods, and the NS-
vesicles exhibit very high MTS to protein ratios compared with
the other systems at equivalent concentrations.
Furthermore, this behaviour can be correlated with the tox-
icity assay. Observe that a high CO to protein ratio, which is
indicative of high MTS internalisation (mean ratio higher than
approximately 0.1), is exhibited by toxic aggregates (bicelles,
rods and NS-vesicles). On the other hand, the other structures
(large and stable to dilution vesicles of both MTSs) cause a
smaller (but quantifiable) complex internalisation giving ratios
below 0.05. Thus, these vesicles are good candidates to act as
CO releasing systems, either by the non-toxic dose of interna-
lised MTS, or by the MTS included in the mixed vesicles that
surround the target cells. In both cases, light irradiation
should trigger CO release and the gas should be delivered
directly into the cells or to their surrounding medium.
Experimental section
General procedures
The preparations and manipulation of MTSs were performed
under a nitrogen atmosphere using standard Schlenk tube
techniques. All the solvents were dried and used freshly dis-
tilled. Tetrahydrofuran and methanol were distilled, respect-
ively, over sodium/benzophenone and magnesium.
Dichloromethane and acetonitrile were also distilled over
sodium hydride, and all of them stored over 3 Å molecular
sieves.
MTS preparation
MTSs Mo(CO)5L6 (PCOL6) and Mo(CO)4L6 (TCOL6) were pre-
pared using previously reported methods.15,16
Preparation of mixed aggregates of phosphatidylcholine and
MTSs by the thin film method
The appropriate volumes of chloroform/methanol (1 : 2 v/v)
stock solutions of soybean phosphatidylcholine (SPC) and
MTSs were mixed in order to achieve their desired final con-
centrations and molar ratios. The mixture was rotavapored and
the homogeneous thin dry films obtained were kept under
vacuum overnight. Subsequently the films were hydrated and
the suspensions stirred for at least 30 minutes before any
experiment.
Preparation of mixed aggregates of phosphatidylcholine and
MTSs by microfluidification
Mixed aggregated MTS/SPC vesicles were obtained using a
micromixer (moulded channels of 300 × 79 µm width × height)
on a NanoAssemblr™ (Precision NanoSystems Inc., Vancouver,
Fig. 9 Intensity ratio of the CO band of the MTS to the amide I band (cell protein) after treatment of cell cultures for 12 h with TCOL6/SPC or
PCOL6/SPC aggregates at several concentrations. Black lines into the boxes represent the median, the green dotted lines are the mean and whiskers
are the 9th and the 91st percentiles. Signiﬁcant diﬀerences (P) of the median are shown below the number (n) of spectra acquired. The MTS to SPC
molar ratios were 1 : 3 for TCOL6 and PCOL6 stable vesicles; 3 : 3 for TCOL6/SPC bicelles; 10 : 3 for PCOL6/SPC non-stable vesicles (NS-vesicles);
and 10 : 3 for TCOL6/SPC rods.
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Canada). SPC and MTS were dissolved at the desired concen-
tration and molar ratio in ethanol or methanol, and the vesi-
cles were obtained by injecting the solvent and an aqueous
solution into the micromixer. The factors that were regulated
are: the Flow Rate Ratio (FRR) between the aqueous and the
solvent streams (aqueous/solvent from 1 to 5); the Total Flow
Rate (TFR) of the solvent and aqueous streams (from 2 to
18 mL min−1); and the ionic strength of the aqueous medium
(from 0 to 155 mM of NaCl). To study the eﬀect of FRR and
TFR on the vesicle size a central composite design, comple-
mented with perimetral level combinations, was used.21 After
processing the samples under the desired conditions the
solvent was removed using size exclusion chromatography
columns (Sephadex G-75) and the size distribution of the
aggregates was measured by DLS. The relationship between
the factors (FRR and TFR) and the response (mean diameter)
was calculated by the stepwise method, fitting empirical, full
second-order polynomial models that include constant, first-
order, second-order, and interaction terms. After the corre-
lations were carried out, the final equations contained only the
significant parameters.
Dynamic light scattering measurements
The size distribution of the aggregates was measured by
dynamic light scattering using an Ultrafine Particle Analyzer
UPA150 (USA) or a Zetasizer 4 (Malvern Instruments, Malvern,
UK). The results are expressed as volume distribution (n ≥ 3).
Cryo-TEM and optical microscopy images
Transmission electron microscopy images were obtained at the
Microscopy Services of the Universitat Autònoma de Barcelona
using a Jeol JEM-1400 electron microscope operating at 120
kV. Optical microscopy pictures were acquired with an inverted
phase contrast microscope IMT-2 Olympus, and samples were
blotted onto a Neubauer chamber.
Monitorization of CO release by FTIR spectroscopy
Samples were exposed to UVA light (a Spectroline lamp;
maximum wavelength intensity at 365 nm) or visible light (a
Seon halogen lamp filtered with a Kodak Wraten 2B cut-oﬀ
filter to eliminate any UV residual radiation) and, at diﬀerent
times, aliquots were taken and frozen at −80 °C. The evolution
of the CO infrared bands of MTS upon irradiation was detected
analyzing the aliquots with a Varian 660-IR FTIR spectrometer
at the Laboratory of Luminescence and Biomolecular
Spectroscopy of the Universitat Autònoma de Barcelona. Once
defrozen, aliquots were blotted on IR windows and dried in a
desiccator connected to a vacuum pump. The spectra (resolu-
tion 1 cm−1; 50 scans) were normalized to the area of the SPC
CO band at 1730 cm−1 (this group is not altered during
irradiation) and the area ratios between the MTS CO
(2071 cm−1 and 2019 cm−1 for PCOL6 and TCOL6, respectively)
and SPC CO bands were obtained.
Toxicity studies
Cell viability of human dermal fibroblasts after incubation
with diﬀerent MTS/SPC systems was carried out by the XTT
assay. The cells were seeded at a concentration of 7.5 × 104
cells per mL in DMEM 10% SBF and after confluence were
maintained in DMEM 1% SBF for 24 h. Incubations with
increasing concentrations of MTS suspensions diluted in cell
medium (DMEM 1% SBF) were performed for 24 h.
Subsequently, the medium was absorbed, the cells rinsed with
PBS (0.1 mL) and the cell medium and the reagent were
added. Absorbance at 450 nm was read after incubation for 4 h
at 37 °C.
FTIR microscopy studies using synchrotron radiation
Internalization studies of MTS/SPC aggregates were carried out
using human dermal fibroblasts cultured on infrared CaF2
windows at 70% confluence. The samples were treated for 12 h
with diﬀerent formulations diluted in cell medium (DMEM
1% SBF) at the desired concentrations of MTS. A blank con-
taining no MTS and 150 µM of SPC liposomes was included.
Once the incubation medium was aspirated, the cells were
rinsed three times with 0.5 mL of PBS and fixed with 0.5 mL of
4% paraformaldehyde for 30 minutes. After fixation the cells
were rinsed with deionized water. The samples were observed
with a Hyperion 3000 microscope equipped with a 36× magni-
fication objective coupled to a Vertex 80 spectrometer (Bruker)
at the MIRAS beamline at Alba Synchrotron (Catalunya,
Spain).28 The spectra were acquired with an optical window of
8 × 8 μm.
The presence of MTS in the spectra was detected perform-
ing Principal Component Analysis (PCA) of the region that con-
tains the CO absorption bands of the MTS. After rejecting
spectra with strong Mie scattering, a baseline correction was
carried out, and the second derivative of the spectra was used
to eliminate any baseline influence in the position of the
peaks. The PCA plots allowed quantifying the percentage of
outlier spectra of a given treatment referred to the control
(non-treated ells). The relative amount of MTS in the cells was
obtained by the ratio between the absorbance of a character-
istic CO band of the MTS and that of the amide I band, corres-
ponding to the cell protein.
Conclusions
We have demonstrated that, depending on their molar ratio,
TCOL6 and PCOL6 can form several types of aggregated
systems when mixed with phospholipids. Large vesicles, nano-
metric bicelles, and micrometre-sized rods are obtained,
which shows a higher aggregate variability than that of the
TCOL2 and PCOL2 systems. Thus, though the L6 family leads
to the production of vesicles at low MTS/SPC ratios (as is the
case with the L2 family), at high MTS/SPC ratios new structures
are formed, like small bicelles, big rods and irregular vesicles.
Therefore, the increase of the length of the hydrocarbon chain
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has a relevant influence on the aggregation properties of the
mixed MTS/SPC systems.
In a similar way to the L2 family, TCOL6 and PCOL6 mixed
systems are also capable of releasing CO when activated by
UVA and visible light. Among all of them, stable to dilution
MTS/SPC vesicles appear to be a good candidate for further
biomedical applications, since they cause a non-toxic internal-
isation of MTS into the cells.
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